CHI Board of Directors

CHI Chairman
George A. Scangos, Ph.D.
Chief Executive Officer
Biogen Idec

CHI President and CEO
David L. Gollaher, Ph.D.
California Healthcare Institute

CHI Board of Director Committees

Chairman, Biopharmaceutical Sector Policy Committee
David E.I. Pyott
Chairman of the Board and CEO
Allergan

Chairman, CHI Audit Committee
Tracy T. Lefteroff
National Life Sciences Partner
PricewaterhouseCoopers

Chairman, CHI Finance Committee
Lawrence P. Guiheen
President, BioPharmaceuticals
Baxter BioScience

Chairman, CHI Membership Committee
Peter G. Milner, M.D., F.A.C.C.
President, Co-Founder and, Member Board of Directors ARYx Therapeutics, Inc.
ARYx Therapeutics, Inc.

Chairman, CHI Nominating and Governance Committee
John C. Martin, Ph.D.
Chairman and CEO
Gilead Sciences 

Chairman, Medical Technologies Sector Policy Committee
Robert B. Hance
President
Abbott Vascular

Chairman, Research & Education Sector Policy Committee
Susan M. Baxter, Ph.D.
Executive Director
California State University